$1.54
0.76% today
Nasdaq, Apr 01, 07:06 pm CET
ISIN
US54303L1044
Symbol
LGVN
Sector
Industry

Longeveron Inc - Ordinary Shares - Class A Stock price

$1.55
+0.03 1.97% 1M
-0.39 20.10% 6M
-0.18 10.40% YTD
-1.30 45.61% 1Y
-136.45 98.88% 3Y
-98.45 98.45% 5Y
-98.45 98.45% 10Y
Nasdaq, Closing price Mon, Mar 31 2025
-0.03 1.90%
ISIN
US54303L1044
Symbol
LGVN
Sector
Industry

Key metrics

Market capitalization $23.18m
Enterprise Value $5.40m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 2.26
P/S ratio (TTM) P/S ratio 9.70
P/B ratio (TTM) P/B ratio 1.05
Revenue growth (TTM) Revenue growth 237.38%
Revenue (TTM) Revenue $2.39m
EBIT (operating result TTM) EBIT $-16.52m
Free Cash Flow (TTM) Free Cash Flow $-14.52m
Cash position $19.23m
EPS (TTM) EPS $-4.05
P/E forward negative
P/S forward 9.81
EV/Sales forward 2.28
Short interest 4.01%
Show more

Is Longeveron Inc - Ordinary Shares - Class A a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,804 stocks worldwide.

Longeveron Inc - Ordinary Shares - Class A Stock Analysis

Unlock Scores for Free

Analyst Opinions

3 Analysts have issued a Longeveron Inc - Ordinary Shares - Class A forecast:

3x Buy
100%

Analyst Opinions

3 Analysts have issued a Longeveron Inc - Ordinary Shares - Class A forecast:

Buy
100%

Financial data from Longeveron Inc - Ordinary Shares - Class A

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
2.39 2.39
237% 237%
100%
- Direct Costs 1.47 1.47
3% 3%
62%
0.93 0.93
229% 229%
39%
- Selling and Administrative Expenses 9.31 9.31
17% 17%
390%
- Research and Development Expense 7.18 7.18
12% 12%
300%
-16 -16
23% 23%
-651%
- Depreciation and Amortization 0.96 0.96
1% 1%
40%
EBIT (Operating Income) EBIT -17 -17
21% 21%
-691%
Net Profit -16 -16
25% 25%
-668%

In millions USD.

Don't miss a Thing! We will send you all news about Longeveron Inc - Ordinary Shares - Class A directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Longeveron Inc - Ordinary Shares - Class A Stock News

Neutral
GlobeNewsWire
21 days ago
Phase 2a results demonstrated laromestrocel (Lomecel-B™) improved cognitive function, quality of life, and brain volume in the treatment of mild Alzheimer's disease This encouraging clinical trial data adds to the body of evidence supporting the safety of single and multiple doses of laromestrocel (Lomecel-B™) treatment for mild Alzheimer's disease and provides indications of efficacy in combat...
Neutral
GlobeNewsWire
27 days ago
MIAMI, March 05, 2025 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions, today announced that it will participate in the 37th Annual Roth Conference taking place March 17-18, 2025. Details for the Company's fireside chat:   Date: Tuesday, March 1...
Neutral
Seeking Alpha
about one month ago
Longeveron Inc. (NASDAQ:LGVN ) Q4 2024 Earnings Conference Call February 28, 2025 4:30 PM ET Company Participants Derek Cole - IR, Advisory Solutions Wa'el Hashad - CEO Nataliya Agafonova - CMO Lisa Locklear - CFO Conference Call Participants Boobalan Pachaiyappan - ROTH Capital Partners Ram Selvaraju - H.C. Wainwright Michael Okunewitch - Maxim Group Operator Good day, and welcome to the Longe...
More Longeveron Inc - Ordinary Shares - Class A News

Company Profile

Longeveron LLC is a clinical stage biotechnology company that engages in the development of cellular therapies for specific aging-related and life-threatening conditions. Its lead product, LOMECEL-B, is a cell-based therapy product, which is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young healthy adult donors. The company was founded by Joshua M. Hare and Donald M. Soffers in October 9, 2014 and is headquartered in Miami, FL.

Head office United States
CEO Mohamed Hashad
Employees 26
Founded 2014
Website www.longeveron.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today